YASMIN® (drospirenone and ethinyl estradiol) is a low-dose, monophasic oral contraceptive and the first and only birth control pill to contain the unique progestin, drospirenone. Its market entry represents further expansion of the Berlex leadership in contraception. The launch of YASMIN® continues in the tradition of Berlex's parent company, which introduced oral contraceptives in the European market 40 years ago. Over 4 million women worldwide are currently using YASMIN®. The product has been available in several European countries, including Germany, since November of 2000. It was launched in the U.S. June 2001.